NO20081809L - Glukuronatsalt av en piperazinforbindelse - Google Patents
Glukuronatsalt av en piperazinforbindelseInfo
- Publication number
- NO20081809L NO20081809L NO20081809A NO20081809A NO20081809L NO 20081809 L NO20081809 L NO 20081809L NO 20081809 A NO20081809 A NO 20081809A NO 20081809 A NO20081809 A NO 20081809A NO 20081809 L NO20081809 L NO 20081809L
- Authority
- NO
- Norway
- Prior art keywords
- piperazine compound
- glucuronate salt
- salt form
- salt
- glucuronate
- Prior art date
Links
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical class OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 title abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- -1 piperazine compound Chemical class 0.000 title 1
- 150000003839 salts Chemical group 0.000 abstract 2
- SDAMYSWGWHXMRT-UHFFFAOYSA-N 8-[4-[3-(5-fluoro-1h-indol-3-yl)propyl]piperazin-1-yl]-2-methyl-4h-1,4-benzoxazin-3-one Chemical compound C1=C(F)C=C2C(CCCN3CCN(CC3)C3=CC=CC4=C3OC(C(N4)=O)C)=CNC2=C1 SDAMYSWGWHXMRT-UHFFFAOYSA-N 0.000 abstract 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 abstract 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 abstract 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940097043 glucuronic acid Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71616705P | 2005-09-12 | 2005-09-12 | |
| PCT/US2006/035517 WO2007033191A1 (fr) | 2005-09-12 | 2006-09-12 | Sel glucuronate d'un compose piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081809L true NO20081809L (no) | 2008-04-14 |
Family
ID=37603202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081809A NO20081809L (no) | 2005-09-12 | 2008-04-14 | Glukuronatsalt av en piperazinforbindelse |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7595310B2 (fr) |
| EP (1) | EP1940830A1 (fr) |
| JP (1) | JP2009507921A (fr) |
| KR (1) | KR20080045285A (fr) |
| CN (1) | CN101287730B (fr) |
| AR (1) | AR056506A1 (fr) |
| AU (1) | AU2006291058B2 (fr) |
| BR (1) | BRPI0615853A2 (fr) |
| CA (1) | CA2620755A1 (fr) |
| EA (1) | EA014942B1 (fr) |
| GT (1) | GT200600414A (fr) |
| IL (1) | IL189809A0 (fr) |
| MY (1) | MY144782A (fr) |
| NO (1) | NO20081809L (fr) |
| PE (1) | PE20070433A1 (fr) |
| SA (1) | SA06270329B1 (fr) |
| TW (1) | TW200800974A (fr) |
| UA (1) | UA95922C2 (fr) |
| WO (1) | WO2007033191A1 (fr) |
| ZA (1) | ZA200802310B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| TW200800306A (en) | 2005-09-12 | 2008-01-01 | Wyeth Corp | Sustained-release formulation and uses thereof |
| GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
| KR20150023937A (ko) * | 2007-05-11 | 2015-03-05 | 리히터 게데온 닐트. | 카르바모일-사이클로헥산 유도체의 신규한 용매화물 및 결정 형태 |
| HUP0700353A2 (en) | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
| GEP20146052B (en) | 2008-07-16 | 2014-03-10 | Richter Gedeon Vegyeszeti Gyar Rt | Pharmaceutical formulations containing dopamine receptor ligands |
| HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
| HUP0800766A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Vegyeszet | Process for the preparation of piperazine derivatives |
| HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
| WO2014031162A1 (fr) | 2012-08-20 | 2014-02-27 | Forest Laboratories Holdings Limited | Forme cristalline de dérivés de carbamoyl-cyclohexane |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4438119A (en) * | 1982-12-23 | 1984-03-20 | Mead Johnson & Company | Method for alleviation of extrapyramidal motor disorders |
| US4687772A (en) * | 1986-10-07 | 1987-08-18 | Bristol-Myers Company | Method for improvement of short term memory |
| US4771053A (en) * | 1987-03-02 | 1988-09-13 | Bristol-Myers Company | Method for alleviation of primary depressive disorders |
| US5162375A (en) * | 1988-05-06 | 1992-11-10 | Beecham Group P.L.C. | Treatment of neuronal degeneration with 5HT1A agonists |
| DE4135551A1 (de) | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
| US5824680A (en) * | 1991-08-31 | 1998-10-20 | Bayer Aktiengesellschaft | Ipsapirone for the treatment of alzheimer's disease by improving memory |
| US5716960A (en) * | 1995-01-13 | 1998-02-10 | U.S. Bioscience Inc. And Individuals | Crystalline trimetrexate salts and the process for making the same |
| SE9900190D0 (sv) | 1999-01-22 | 1999-01-22 | Astra Ab | New compounds |
| DE19730989A1 (de) * | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
| DE69819173T2 (de) * | 1997-07-25 | 2004-04-15 | H. Lundbeck A/S | Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung |
| HN1999000146A (es) | 1998-09-21 | 2000-11-11 | Pfizer Prod Inc | Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas. |
| CN1155596C (zh) * | 1999-08-23 | 2004-06-30 | 索尔瓦药物有限公司 | 新的苯基哌嗪 |
| BR0107721A (pt) | 2000-01-19 | 2002-10-01 | Akzo Nobel Nv | Combinação, uso de mirtapazina e gepirona, método para o tratamento de depressão ou de um distúrbio relacionado em um indivìduo de uma espécie vertebrada, e, kit de paciente que contém meios para a administração de doses unitárias dosadas |
| AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
| MXPA06001636A (es) * | 2003-08-13 | 2006-04-28 | Amgen Inc | Antagonista del receptor de la hormona concentradora de melanina. |
| US20050197347A1 (en) | 2003-12-18 | 2005-09-08 | Judith Aronhime | Polymorphic form B2 of ziprasidone base |
| GT200600416A (es) * | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
| TW200800306A (en) * | 2005-09-12 | 2008-01-01 | Wyeth Corp | Sustained-release formulation and uses thereof |
| GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine |
-
2006
- 2006-09-08 GT GT200600414A patent/GT200600414A/es unknown
- 2006-09-11 PE PE2006001091A patent/PE20070433A1/es not_active Application Discontinuation
- 2006-09-11 AR ARP060103944A patent/AR056506A1/es not_active Application Discontinuation
- 2006-09-11 TW TW095133454A patent/TW200800974A/zh unknown
- 2006-09-12 US US11/519,756 patent/US7595310B2/en not_active Expired - Fee Related
- 2006-09-12 MY MYPI20080551A patent/MY144782A/en unknown
- 2006-09-12 BR BRPI0615853-6A patent/BRPI0615853A2/pt not_active IP Right Cessation
- 2006-09-12 KR KR1020087008818A patent/KR20080045285A/ko not_active Ceased
- 2006-09-12 SA SA06270329A patent/SA06270329B1/ar unknown
- 2006-09-12 CA CA002620755A patent/CA2620755A1/fr not_active Abandoned
- 2006-09-12 CN CN2006800382372A patent/CN101287730B/zh not_active Expired - Fee Related
- 2006-09-12 AU AU2006291058A patent/AU2006291058B2/en not_active Ceased
- 2006-09-12 EA EA200800810A patent/EA014942B1/ru not_active IP Right Cessation
- 2006-09-12 EP EP06803440A patent/EP1940830A1/fr not_active Withdrawn
- 2006-09-12 JP JP2008531254A patent/JP2009507921A/ja active Pending
- 2006-09-12 WO PCT/US2006/035517 patent/WO2007033191A1/fr not_active Ceased
- 2006-12-09 UA UAA200804630A patent/UA95922C2/ru unknown
-
2008
- 2008-02-27 IL IL189809A patent/IL189809A0/en unknown
- 2008-03-11 ZA ZA200802310A patent/ZA200802310B/xx unknown
- 2008-04-14 NO NO20081809A patent/NO20081809L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0615853A2 (pt) | 2011-05-31 |
| CN101287730A (zh) | 2008-10-15 |
| GT200600414A (es) | 2007-09-20 |
| WO2007033191A1 (fr) | 2007-03-22 |
| MY144782A (en) | 2011-11-15 |
| EA014942B1 (ru) | 2011-04-29 |
| KR20080045285A (ko) | 2008-05-22 |
| AU2006291058B2 (en) | 2011-09-08 |
| EA200800810A1 (ru) | 2008-10-30 |
| AR056506A1 (es) | 2007-10-10 |
| EP1940830A1 (fr) | 2008-07-09 |
| AU2006291058A1 (en) | 2007-03-22 |
| UA95922C2 (en) | 2011-09-26 |
| SA06270329B1 (ar) | 2010-06-15 |
| CN101287730B (zh) | 2012-03-07 |
| US7595310B2 (en) | 2009-09-29 |
| PE20070433A1 (es) | 2007-04-24 |
| US20070254876A1 (en) | 2007-11-01 |
| TW200800974A (en) | 2008-01-01 |
| JP2009507921A (ja) | 2009-02-26 |
| ZA200802310B (en) | 2008-12-31 |
| IL189809A0 (en) | 2008-08-07 |
| CA2620755A1 (fr) | 2007-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081809L (no) | Glukuronatsalt av en piperazinforbindelse | |
| DK1392714T3 (da) | Steroider som agonister for FXR | |
| WO2008006044A3 (fr) | Dérivés d'acides substitués utiles comme agents antidiabète et antiobésité et procédé | |
| BRPI0508098A (pt) | compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos | |
| CY1113029T1 (el) | Παραγωγα αζαδικυκλο [3.1.0] εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης | |
| TW200801814A (en) | Positive resist composition and pattern formation method using the same | |
| CA2492096A1 (fr) | Derives de 1-h-pyrrolidin-2,4-dione spirocyclique cis-alcoxysubstituee utilises comme insecticides | |
| BR0212871A (pt) | Concentrado fomador de microemulsão, microemulsão e métodos de aplicar uma composição herbicida e um herbicida e de preparar um concentrado formador de microemulsão e uma microemulsão | |
| CL2008003684A1 (es) | Composicion farmaceutica que comprende una sal de aluminio, que tiene una relacion molar de aluminio a cloruro de 0,3:1 a 3:1 aproximadamente, ademas comprende zirconio; metodo de preparacion de la composicion; uso como antitranspirante. | |
| TW200531683A (en) | Aryl- and heteroarylpiperidinecarboxylate derivatives, their preparation and their application in therapeutics | |
| WO2006102163A3 (fr) | Reactifs de transfection pour cellules en suspension non adherentes | |
| CY1110034T1 (el) | Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| CY1107368T1 (el) | Νεα παραγωγα 4-βενζυλιδενο-πιπεριδινης | |
| ECSP045221A (es) | Sales de valsartan | |
| NO20076680L (no) | Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter | |
| NO20072753L (no) | 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer | |
| DK1611144T3 (da) | Derivater af 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl-phosphonsyre og deres avendelse som n-methyl-D-aspartat (NMDA)-receptor-antagonister | |
| WO2008130863A3 (fr) | Benzimidazoles substitués | |
| ATE386012T1 (de) | Phenyloxyalkansäure-derivate als hppar aktivatore | |
| WO2008149834A1 (fr) | Dérivé de pyrimidodiazépinone | |
| BR0311410A (pt) | Composto de piperidina | |
| NO20082698L (no) | Nye derivater, deres salter og antisoppmidler inneholdende disse | |
| NO20071634L (no) | Effektiv syntese av 4,5-dihydro-pyrazolo(3,4-C)pyrid-2-oner | |
| GB2429206A (en) | Process for the synthesis of hydromorphone | |
| AU2003294092A1 (en) | Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |